Emmaus Life Sciences
Financial ratios & Valuation
Forward Multiples (2025 – 2025)
| 2025 | |
|---|---|
Price/Earnings ratio | 0.20 |
Price/Sales ratio | 0.02 |
Earnings per Share (EPS) | $0.06 |
Historical Multiples (2014 – 2023)
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | Median | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valuation Ratios
| ||||||||||||
Price/Earnings ratio | -8.39 | -1.80 | -0.64 | -1.50 | -0.86 | -1.51 | 44.41 | -5.15 | -1.20 | -1.42 | -0.74 | -0.86 |
Price/Sales ratio | 165.42 | 61.02 | 45.25 | 83.53 | 6.28 | 3.65 | 2.59 | 3.99 | 0.69 | 0.17 | 0.60 | 3.65 |
Price/Book Value ratio | -12.68 | -1.26 | -15.01 | 2.36 | 2.05 | -7.53 | -11.09 | -3.83 | -0.37 | -0.11 | -0.46 | -0.46 |
Price/Cash Flow ratio | -6.83 | -2.88 | -1.29 | -2.24 | -0.91 | -18.40 | -24.53 | -65.59 | -2.53 | -3.53 | -1.45 | -1.45 |
Price/Free Cash Flow ratio | -6.70 | -2.88 | -1.25 | -2.18 | -0.90 | -18.16 | -2.10 | -61.98 | -2.52 | -3.49 | -1.44 | -1.44 |
Price/Earnings Growth ratio | 0.10 | -0.07 | -0.01 | 0.02 | 0.03 | 0.01 | -0.43 | 0.00 | 0.03 | 0.02 | -0.04 | 0.01 |
Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Profitability Indicator Ratios
| ||||||||||||
Gross Profit Margin | 45.96% | 95.10% | 93.53% | 58.36% | 37.10% | 95.19% | 90.29% | 83.93% | 85.92% | 95.46% | 84.59% | 37.10% |
Operating Profit Margin | -2825.16% | -2653.74% | -4426.32% | -5528.09% | -778.78% | -19.83% | -0.18% | -29.73% | -35.81% | 11.96% | -42.81% | -778.78% |
Pretax Profit Margin | -1965.13% | -3377.62% | -6978.73% | -5533.22% | -785.34% | -240.32% | 3.10% | -77.24% | -57.77% | -12.81% | -80.73% | -785.34% |
Net Profit Margin | -1970.98% | -3376.02% | -6981.08% | -5535.25% | -729.66% | -241.04% | 5.84% | -77.37% | -58.10% | -12.61% | -81.27% | -729.66% |
Effective Tax Rate | -0.19% | -0.14% | -0.03% | -0.03% | -0.01% | -0.29% | -52.99% | -0.15% | -0.56% | 1.55% | -0.66% | -0.29% |
Return on Assets | -199.29% | -595.90% | -450.03% | -116.67% | -186.31% | -92.23% | 2.28% | -28.10% | -22.15% | -10.61% | -43.66% | -186.31% |
Return On Equity | 151.15% | 69.87% | 2316.14% | -156.41% | -238.72% | 496.17% | -24.98% | 74.34% | 31.34% | 7.81% | 65.49% | -238.72% |
Return on Capital Employed | 1359.74% | 135.04% | 1709.07% | -156.09% | -256.99% | -16.94% | -0.11% | -31.21% | 108.00% | -13.44% | 181.92% | -256.99% |
Liquidity Ratios
| ||||||||||||
Current Ratio | 0.80 | 0.21 | 0.78 | 3.68 | 3.01 | 1.25 | 0.48 | N/A | N/A | N/A | 0.11 | 1.25 |
Quick Ratio | 0.65 | 0.12 | 0.67 | 3.28 | -1.02 | 1.01 | 0.17 | 0.12 | 0.07 | 0.15 | 0.00 | -1.02 |
Cash ratio | 0.76 | 0.17 | 0.20 | 3.52 | 2.79 | 0.05 | 0.10 | 0.06 | 0.03 | 0.04 | N/A | 0.05 |
Days of Sales Outstanding | 25.12 | 43.02 | 21.87 | 471.51 | 17.56 | 34.49 | 3.11 | 18.41 | 7.44 | 68.12 | 5.28 | 34.49 |
Days of Inventory outstanding | 1.25K | 16.32K | 11.03K | 4.26K | 2.07K | 2.65K | 1.15K | 484.02 | 335.52 | 465.36 | 217.57 | 2.65K |
Operating Cycle | 1.27K | 16.36K | 11.05K | 4.73K | 2.09K | 2.69K | 1.15K | 502.43 | 342.96 | 533.48 | 218.87 | 2.69K |
Days of Payables Outstanding | 4.34K | 23.70K | 28.31K | 5.02K | 153.03 | 2.42K | 328.46 | 28.87 | 42.45 | 351.40 | 1.23K | 153.03 |
Cash Conversion Cycle | -3.06K | -7.33K | -17.25K | -289.87 | 1.94K | 266.03 | 825.34 | 473.56 | 300.51 | 182.08 | -1.18K | 266.03 |
Debt Ratios
| ||||||||||||
Debt Ratio | 1.10 | 7.96 | 0.06 | 0.00 | 0.11 | 0.24 | 0.24 | 0.46 | 0.57 | 0.88 | 1.70 | 0.11 |
Debt Equity Ratio | -0.83 | -0.93 | -0.34 | 0.00 | 0.14 | -1.31 | -2.65 | -1.24 | -0.80 | -0.65 | -2.41 | -1.31 |
Long-term Debt to Capitalization | -5.16 | -1.33 | -0.13 | N/A | 0.12 | N/A | -1.64 | -0.27 | -0.12 | -0.04 | -0.22 | N/A |
Total Debt to Capitalization | -5.24 | -14.14 | -0.51 | 0.00 | 0.12 | 4.15 | 1.60 | 5.12 | -4.22 | -1.89 | -1.36K | 4.15 |
Interest Coverage Ratio | N/A | -10.32 | -1.38 | -1.07K | -118.71 | -0.16 | -0.00 | N/A | N/A | N/A | -1.57 | -118.71 |
Cash Flow to Debt Ratio | -2.21 | -0.46 | -33.96 | -152.13 | -15.34 | -0.31 | -0.17 | -0.04 | -0.18 | -0.04 | -0.31 | -15.34 |
Company Equity Multiplier | -0.75 | -0.11 | -5.14 | 1.34 | 1.28 | -5.37 | -10.93 | -2.64 | -1.41 | -0.73 | -1.41 | -1.41 |
Cash Flow Ratios
| ||||||||||||
Operating Cash Flow / Sales Ratio | -24.21 | -21.12 | -34.99 | -37.29 | -6.87 | -0.19 | -0.10 | -0.06 | -0.27 | -0.05 | -0.41 | -6.87 |
Free Cash Flow / Operating Cash Flow Ratio | 1.01 | 1.00 | 1.02 | 1.02 | 1.00 | 1.01 | 11.67 | 1.05 | 1.00 | 1.01 | 1.00 | 1.01 |
Cash Flow Coverage Ratio | -2.21 | -0.46 | -33.96 | -152.13 | -15.34 | -0.31 | -0.17 | -0.04 | -0.18 | -0.04 | -0.31 | -15.34 |
Short Term Coverage Ratio | -934.6 | -1.20 | -52.90 | -152.13 | -6.95K | -0.31 | -0.22 | -0.05 | -0.21 | -0.05 | -0.39 | -6.95K |
Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |